PRHSX - T. Rowe Price Health Sciences

Nasdaq - Nasdaq Delayed Price. Currency in USD
70.19
-4.50 (-6.02%)
At close: 8:00PM EST
Stock chart is not supported by your current browser
Previous Close74.69
YTD Return28.40%
Expense Ratio (net)0.77%
CategoryHealth
Morningstar Rating★★★★★
Morningstar Risk Rating★★★
Last Cap Gain0.00
Net Assets11.68B
Beta (3y)0.87
Yield0.00%
Holdings Turnover24.90%
Last Dividend0.00
Inception DateDec 29, 1995
Average for CategoryN/A
  • Unemployment Rate Remains At 17-Year Low: 5 Fund Picks
    Zacks5 days ago

    Unemployment Rate Remains At 17-Year Low: 5 Fund Picks

    Mutual funds from sectors, which witnessed strong job additions are considered a stable investment.

  • 5 Best-Performing Healthcare Mutual Funds in Q3
    Zackslast month

    5 Best-Performing Healthcare Mutual Funds in Q3

    Broadly encouraging economic conditions, favorable policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money.

  • Forbes4 months ago

    Investing With The Top Biotech Managers

    Biotech stocks have taken off since President Trump took office. Through the end of July, the iShares Biotech ETF is up almost 19%, well ahead of broader market benchmarks. If you are thinking of investing in biotech stocks after this rally, here's what you need to know.

  • Investopedia8 months ago

    Top 4 Healthcare Mutual Funds for 2017

    The healthcare sector is strong this year, despite earlier uncertainty over the ACA. Check out these top mutual funds if you're ready to invest.